Pioneer Pharmaceutical-B (09939): Joseph H J Cheng appointed as Chief Financial Officer

Zhitong Finance App News, Kaituo Pharmaceutical-B (09939) issued an announcement. Mr. Zhang Mingming resigned as the company's chief financial officer and the company's joint company secretary due to personal career development plans. Mr. Cheung Ming-ming also ceased to act as an authorized representative (legal proceeding document agent) to receive legal process documents or notices on behalf of the Company in Hong Kong under Part 16 of the Companies Ordinance, Chapter 622 of the Hong Kong Law. These resignations took effect on September 21, 2026.

Following the resignation of Mr. Zhang Mingming, the Company's other joint company secretary, Mr. Wong Wai-chiu, complied with the requirements of Rules 3.28 and 8.17 of the Hong Kong Stock Exchange Limited Securities Listing Rules. He is eligible to serve as the Company Secretary and will remain and will continue to serve as the Company's sole company secretary, effective from September 21, 2026.

Following the resignation of Mr. Zhang Mingming, Mr. Joseph HJ Cheng has been appointed as the Chief Financial Officer of the Company with effect from September 21, 2026.

Following the resignation of Mr. Zhang Mingming, Lian Shao'e has been appointed as the Company's legal procedure agent to replace her position with effect from September 21, 2026.